SPAP27G11.16 Antibody

What is SPAP27G11.16 protein and why is it significant in yeast research?

SPAP27G11.16 is a protein encoded by the SPAP27G11.16 gene (Entrez Gene ID: 2541665) in Schizosaccharomyces pombe, commonly known as fission yeast. The protein is significant in yeast research as it represents one of the model organisms' proteins that helps understand fundamental cellular processes. Fission yeast is widely used in molecular and cellular biology research because its cellular processes closely resemble those in higher eukaryotes, including humans. The SPAP27G11.16 protein has been assigned the UniProt number Q9C109, indicating its recognition in protein databases . Methodologically, researchers studying this protein should consider comparative analyses with related proteins in other model organisms to establish evolutionary relationships and potential functional conservation.

How does the polyclonal nature of SPAP27G11.16 antibody impact experimental design?

The polyclonal nature of the SPAP27G11.16 antibody has significant implications for experimental design in research settings. Polyclonal antibodies like this one contain a mixture of immunoglobulins that recognize multiple epitopes on the target antigen, providing higher sensitivity but potentially lower specificity compared to monoclonal antibodies. When designing experiments, researchers should consider that this antibody was generated in rabbits using recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAP27G11.16 protein as the immunogen . This affects experimental considerations in several ways:

• Sensitivity vs. Specificity balance: The polyclonal nature enhances detection sensitivity, especially in applications like Western blotting where the protein may be partially denatured.

• Cross-reactivity potential: Researchers must include proper controls (the provided pre-immune serum) to distinguish specific from non-specific binding.

• Lot-to-lot variability: Unlike monoclonal antibodies, polyclonal preparations may vary between production batches.

• Epitope accessibility: Multiple epitope recognition can be advantageous when the target protein exists in different conformational states.

For rigorous experimental design, researchers should always include the provided positive control (200μg antigens) and negative control (1ml pre-immune serum) in parallel with experimental samples .

What are the optimal protocols for using SPAP27G11.16 antibody in Western blotting applications?

When using SPAP27G11.16 antibody in Western blotting applications, researchers should follow this optimized protocol based on current methodological research:

Sample Preparation:

• Extract total protein from S. pombe cultures using glass bead lysis in buffer containing protease inhibitors

• Quantify protein using Bradford or BCA assay

• Prepare samples in SDS-PAGE loading buffer (50-100μg total protein)

Gel Electrophoresis and Transfer:

• Separate proteins on 10-12% SDS-PAGE gel

• Transfer to PVDF membrane (0.45μm pore size preferred for yeast proteins)

• Verify transfer efficiency with reversible staining (Ponceau S)

Immunoblotting:

• Block membrane in 5% non-fat milk in TBST for 1 hour at room temperature

• Dilute SPAP27G11.16 antibody at 1:500 to 1:2000 in blocking solution (titration recommended)

• Incubate membrane with primary antibody overnight at 4°C

• Wash 3-5 times with TBST, 5 minutes each

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000 dilution)

• Wash 3-5 times with TBST, 5 minutes each

• Develop using ECL substrate and image

Controls:

• Include the provided positive control (antigens) at 0.5-1μg per lane

• Run a parallel blot with pre-immune serum at the same dilution as primary antibody

• Include a loading control (e.g., anti-GAPDH)

This methodology incorporates parameters optimized for yeast proteins while accommodating the characteristics of rabbit polyclonal antibodies. The approach is similar to protocols used with other yeast-directed antibodies but tailored to the specific properties of SPAP27G11.16 antibody .

How should researchers optimize ELISA protocols when using SPAP27G11.16 antibody?

For optimizing ELISA protocols with SPAP27G11.16 antibody, researchers should consider the following methodological framework:

Indirect ELISA Protocol:

• Coating:

  • Dilute recombinant SPAP27G11.16 protein or yeast lysate in coating buffer (carbonate-bicarbonate buffer, pH 9.6)

  • Coat 96-well plate with 100μl/well of diluted antigen (concentration 1-10μg/ml)

  • Incubate overnight at 4°C

• Blocking:

  • Wash plate 3 times with PBST (PBS + 0.05% Tween-20)

  • Block with 300μl/well of 3% BSA in PBS for 1-2 hours at room temperature

• Primary Antibody:

  • Prepare serial dilutions of SPAP27G11.16 antibody (starting from 1:100 to 1:10,000)

  • Add 100μl/well of diluted antibody

  • Incubate for 2 hours at room temperature

• Detection:

  • Wash 5 times with PBST

  • Add 100μl/well of HRP-conjugated anti-rabbit IgG (1:5000 in blocking buffer)

  • Incubate for 1 hour at room temperature

  • Wash 5 times with PBST

  • Add 100μl/well of TMB substrate

  • Stop reaction with 50μl/well of 2N H₂SO₄

  • Read absorbance at 450nm

Optimization Table:

This optimization approach addresses the specific requirements of working with yeast proteins while accounting for the polyclonal nature of the SPAP27G11.16 antibody. Always include the provided positive control (antigens) and negative control (pre-immune serum) to establish baseline measurements and ensure specificity .

How can SPAP27G11.16 antibody be used in immunoprecipitation studies to identify protein-protein interactions in yeast?

Employing SPAP27G11.16 antibody for immunoprecipitation (IP) studies requires careful methodological considerations to identify genuine protein-protein interactions in yeast systems. Although IP is not listed among the validated applications for this antibody , many polyclonal antibodies can be adapted for IP with proper optimization. Here's a methodological approach:

Immunoprecipitation Protocol:

• Cell Lysate Preparation:

  • Harvest S. pombe cells from mid-log phase culture (OD₆₀₀ ~0.5-0.8)

  • Lyse cells in non-denaturing lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, protease inhibitors)

  • Clear lysate by centrifugation (14,000g, 10 min, 4°C)

• Pre-clearing (reduces non-specific binding):

  • Incubate lysate with Protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation

• Immunoprecipitation:

  • Add 2-5μg of SPAP27G11.16 antibody to 500μl-1ml of pre-cleared lysate

  • Incubate overnight at 4°C with gentle rotation

  • Add 30-50μl of Protein A beads (effective for rabbit IgG)

  • Incubate for 2-4 hours at 4°C

  • Collect beads by centrifugation and wash 3-5 times with lysis buffer

• Elution and Analysis:

  • Elute bound proteins by boiling in SDS-PAGE sample buffer

  • Analyze by Western blotting or mass spectrometry

Critical Controls:

• Pre-immune serum IP (negative control)

• Input sample (5-10% of lysate used for IP)

• IgG-only control (without lysate)

• Reciprocal IP (if antibodies against putative interacting partners are available)

For mass spectrometry analysis, a more stringent approach using crosslinking agents like DSP (dithiobis[succinimidylpropionate]) may be employed to stabilize transient interactions. The identified interactions should be validated using alternative methods such as yeast two-hybrid assays or FRET analyses to establish biological significance in the context of S. pombe cellular functions.

What strategies can be implemented for quantitative immunofluorescence using SPAP27G11.16 antibody in fission yeast cells?

While immunofluorescence is not among the reported applications for SPAP27G11.16 antibody , this advanced technique could potentially be adapted for visualizing the spatial distribution of the target protein in fission yeast. Here is a methodological framework for researchers attempting quantitative immunofluorescence:

Immunofluorescence Protocol for Fission Yeast:

• Cell Fixation and Permeabilization:

  • Grow S. pombe cells to mid-log phase

  • Fix with 4% formaldehyde for 30 minutes

  • Wash with PBS

  • Permeabilize cell wall using zymolyase (1mg/ml) in sorbitol buffer

  • Permeabilize cell membrane with 0.1% Triton X-100 for 5 minutes

• Blocking and Antibody Incubation:

  • Block with 5% BSA in PBS for 1 hour

  • Incubate with SPAP27G11.16 antibody (1:100-1:500 dilution) overnight at 4°C

  • Wash extensively with PBS

  • Incubate with fluorophore-conjugated anti-rabbit secondary antibody (1:500) for 1 hour

• Mounting and Imaging:

  • Mount cells in antifade medium containing DAPI

  • Image using confocal microscopy with appropriate filter sets

• Quantitative Analysis:

  • Use image analysis software (ImageJ/Fiji) for quantification

  • Measure fluorescence intensity relative to cell area

  • Perform colocalization analysis with organelle markers

Quantification Parameters Table:

Critical to this approach is the inclusion of appropriate controls: pre-immune serum, secondary antibody-only control, and if possible, cells from a SPAP27G11.16 deletion strain. Additionally, researchers should consider the limitations of antibody accessibility in the complex yeast cell architecture and optimize fixation and permeabilization conditions accordingly.

How can researchers validate the specificity of SPAP27G11.16 antibody in their experimental systems?

Validating antibody specificity is crucial for ensuring reliable research outcomes. For SPAP27G11.16 antibody, researchers should implement the following multi-faceted validation strategy:

Methodological Approaches for Specificity Validation:

• Genetic Validation:

  • Compare wildtype S. pombe with SPAP27G11.16 knockout/knockdown strains

  • Expected result: Signal present in wildtype, absent/reduced in knockout

  • Methodological considerations: Use CRISPR-Cas9 or homologous recombination for gene deletion

• Peptide Competition Assay:

  • Pre-incubate antibody with excess recombinant SPAP27G11.16 protein (10-50x molar excess)

  • Apply pre-absorbed antibody in parallel with untreated antibody

  • Expected result: Signal reduction/elimination with pre-absorbed antibody

  • Methodological design: Include concentration gradient of competing peptide

• Orthogonal Detection Methods:

  • Express tagged version of SPAP27G11.16 (e.g., GFP-tagged)

  • Compare detection with SPAP27G11.16 antibody versus anti-tag antibody

  • Expected result: Overlapping detection patterns

  • Methodological approach: Western blot membrane stripping and reprobing

• Cross-species Reactivity Testing:

  • Test antibody against lysates from related yeast species with homologous proteins

  • Expected result: Signal intensity correlating with sequence homology

  • Methodological analysis: Align protein sequences and predict epitope conservation

Specificity Validation Scoring Matrix:

Researchers should aim to satisfy at least three validation methods with strong evidence before proceeding to complex experimental applications. Document all validation steps thoroughly, as journals increasingly require antibody validation data for publication. Always include the provided pre-immune serum as a critical negative control in validation experiments .

What statistical approaches are recommended for analyzing semi-quantitative Western blot data using SPAP27G11.16 antibody?

When analyzing semi-quantitative Western blot data generated using the SPAP27G11.16 antibody, researchers should follow these methodological statistical approaches:

Densitometry Analysis Protocol:

• Image Acquisition:

  • Capture images within linear dynamic range of detection system

  • Use same exposure settings across comparable samples

  • Include a dilution series of control samples for standard curve generation

• Quantification:

  • Use software like ImageJ, Image Lab, or ImageQuant

  • Define lanes and bands systematically

  • Subtract local background from each lane

  • Normalize target protein to loading control (e.g., GAPDH, tubulin)

• Statistical Analysis:

  • For two-group comparisons: Student's t-test (paired or unpaired as appropriate)

  • For multiple group comparisons: One-way ANOVA with appropriate post-hoc test

  • For time-course experiments: Two-way ANOVA or repeated measures ANOVA

  • Perform minimum of 3 biological replicates (n=3)

Statistical Decision-Making Table:

Methodological Considerations:

• Verify normality of data distribution using Shapiro-Wilk test

• Report effect sizes (Cohen's d or partial η²) alongside p-values

• Consider using ROUT or Grubbs' test for outlier identification

• For densitometry values, use relative fold-change rather than absolute values

• Report 95% confidence intervals for all measurements

Researchers should be aware that Western blot is inherently semi-quantitative, and findings should be validated using complementary approaches. When publishing results, include representative images alongside quantification and clearly state the number of independent biological and technical replicates. Detailed methodological reporting enhances reproducibility across different laboratory settings.